Directorate Change

RNS Number : 5754Z
EMIS Group PLC
21 September 2015
 

 

EMIS Group plc

Appointment of Non-Executive Director

EMIS Group plc ("the Company") is pleased to announce that, further to the Company announcement on 2 April 2015, Andrew McKeon will be reappointed as a Non-Executive Director of the Company and as Chair of the Remuneration Committee with effect from 30 September 2015.

Mike O'Leary, Chairman of the Company, said:

"We are delighted to reappoint Andy as a Non-Executive Director following his agreed leave of absence. His considerable knowledge of NHS healthcare is invaluable to the Board and we welcome him back to the team."

Andrew John McKeon, aged 59, has the following current and previous directorships in the past five years.

Current:

Non-executive Director at the National Institute of Health and Care Excellence (NICE)

 

Previous:

Nuffield Trading Limited

Nuffield Trust for Research and Policy Studies in Health Services

EMIS Group plc

 

There are no further disclosures to be made in accordance with Schedule Two paragraph (g) of the AIM Rules in connection with the appointment.

 

Enquiries:

For further information, contact:

 

EMIS Group plc                                                                                                 Tel: 0113 380 3000

Chris Spencer, CEO

Peter Southby, CFO

www.emisgroupplc.com

 

Numis Securities Limited (Nominated Adviser & Broker)             Tel: 020 7260 1000

Adrian Trimmings/Simon Willis/James Black

 

MHP Communications                                                                                  Tel: 020 3128 8540

Reg Hoare/Giles Robinson/Charlie Barker                          

 

 

Notes to Editors

 

EMIS Group is the UK leader in connected healthcare software and services. Its solutions are widely used across every major UK healthcare setting from primary and community care, to high street pharmacies, secondary care and specialist services. EMIS Group helps clinicians, in over 10,000 organisations, share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.

 

EMIS Group serves the following healthcare markets under the EMIS Health brand:

 

•      Primary and Community Care, the UK leader in clinical IT systems for GPs and commissioners. EMIS Health products, including the flagship EMIS Web, hold over 40 million patient records and are used by nearly 6,000 healthcare organisations, including community-based teams.

•      Community Pharmacy, the UK's single most used integrated community pharmacy and retail system.

•      Secondary and Specialist Care, a leading software provider to 81% of the UK's NHS Acute Trusts and Boards, focused primarily on Hospital Pharmacy, A&E (holding over 30 million patient records), Mental Health and Patient Administration Systems as well as England's leading provider of diabetic eye screening and other ophthalmology-related solutions.

 

These markets are also supported by other EMIS Group businesses:

•      under the Patient brand, the UK's leading independent provider of patient-centric medical and well-being information and related transactional services

•      under the Egton brand, providing specialist ICT infrastructure, solutions, hardware and engineering services

•      under the EMIS Care brand, providing healthcare screening programmes such as diabetic eye screening programmes



 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPKFDDPBKDFCD

Companies

EMIS Group (EMIS)
UK 100

Latest directors dealings